The percentage of US adults reporting high confidence in the CDC fell from 82% in February 2020 to 56% in June 2022.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
While Medicare beneficiary hospitalizations for non–COVID-19 diagnoses fell sharply in March and April 2020 and stayed low through September 2021, death rates after hospitalization rose substantially—particularly for Black and Hispanic patients, finds a study yesterday in JAMA Network Open.
"These findings imply that the pandemic may substantially contribute to the world dementia burden."
The United States continues to report the most COVID-19 fatalities of any country.
Continuing the corticosteroid dexamethasone after hospital release didn't benefit COVID-19 patients who didn't complete the 10-day drug regimen during their stay, finds a study published yesterday in JAMA Network Open.
The imaging differences between COVID-19 and non-COVID patients were modest, about 2%.
Different approaches may be needed in the future, experts say, such as vaccines that target a specific variant.
Fully 92% of side effects during the first 6 months of the US vaccine rollout were mild and short-lived.
Three percent of 10,403 adults with COVID-19 pneumonia were diagnosed as having new-onset dementia after a median of 182 days, a significantly higher proportion than that observed with other types of pneumonia, finds a study yesterday in Open Forum Infectious Diseases.
The roadmap advises against school closings, lobbies for more tests, and details when restrictions should lift.
Concerns are growing that continued spread could create COVID-19 virus reservoirs in animals.
